Agenda

Articles

• Meet Vect-Horus at BIO Spring Basel, Switzerland, March 20–22, 2023
  17 February 2023, by Elodie DORMES

  Emmanuelle BETTENDORF will participate in BioEurope Spring from March 20 to 22, 2023 and will be available to meet with you on partnership opportunities.

• Happy new year !
  2 January 2024, by Emmanuelle BETTENDORF

  The Vect-Horus teams join to wish you a Happy Holiday season and Best Wishes for 2024.

• Vect-Horus will participate to the HealthTech Innovation Days on November 13-14, 2022
  11 October 2022, by Elodie DORMES

  Elodie DORMES, Business Development Manager, will attend the HealthTech Innovation Days in Paris on November 13-14, 2022.
  2 days dedicated to networking and interaction with Biotech and Pharmaceutical companies.

• Meet Vect-Horus at the 36th PAMM-EORTC Winter meeting
  28 January 2019, by Jonathan NOWAK

  Pharmacology and Molecular Mechanisms Group (PAMM) of the European Organisation for Research and Treatment of Cancer (EORTC).
  Meet VECT-HORUS at the 36th PAMM-EORTC Winter meeting, Marseille, France
  January 21-24, 2015

• Meet Vect-Horus at BIO Spring Barcelona
  28 January 2019, by Jonathan NOWAK

  March 20-22 // Barcelona, SPAIN

• Meet Vect-Horus at BIO-Europe Spring® 2015
  28 January 2019, by Jonathan NOWAK

  Meet VECT-HORUSat BIO-Europe Spring® 2015, Paris, France
  March 9-11, 2015

• Meet Vect-Horus at San Diego, California, June 3-6, 2024
  21 May 2024, by Emmanuelle BETTENDORF

  Next month, Emmanuelle Bettendorf will be attending the BIO International Convention, a major biotech industry conference taking place in San Diego, CA from June 3-6, 2024, and will be available to meet with you on partnership opportunities.
  Looking forward to seeing you there!

• Meet Vect-Horus at OTS, Montreal, October 6-9, 2024
  2 October 2024, by Emmanuelle BETTENDORF

  Guillaume Jacquot and Emmanuelle Bettendorf will be representing Vect-Horus at the The Oligonucleotide Therapeutics Society (OTS) Annual Meeting, taking place in Montreal, Canada from October 6-9.
  This is the leading international meeting of renowned oligonucleotide scientists, bringing academia, research and business together, and we are excited to swap notes with other leading players in the field.
  👉 Click here for more on the meeting www.2024oligomeeting.com

• BIO International Convention in BOSTON, MA
  28 January 2019, by Jonathan NOWAK

  The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships.
  VECT-HORUS’ business model is to make its technology platform available to pharmaceutical and biotech partners to transport their drug to the brain and other organs using feasibility studies. Subsequently, the Company will license-out its technology. VECT-HORUS is also building proprietary (…)

• Biopharm America 2015
  28 January 2019, by Jonathan NOWAK

  VECT-HORUS will be present at Biopharm America 2015.